Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2015
Multicolor Digital Flow Cytometry in Human Translational ImmunologySamit R Joshi, Subhasis Mohanty, Albert C ShawThe Yale Journal of Biology and Medicine|December 23, 2009
Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccineSamit R Joshi, Albert C Shaw, Vincent J QuagliarelloAgeing Research Reviews|November 16, 2010
Dysregulation of human Toll-like receptor function in agingAlbert C Shaw, Alexander Panda, Samit R Joshi, et al.Clinical Pharmacology in Drug Development|January 7, 2022
Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy ParticipantsMark Johnson, Teodora Pene Dumitrescu, Samit R Joshi, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2017
Viral Drug Resistance Through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, FostemsavirMax Lataillade, Nannan Zhou, Samit R Joshi, et al.Bioinformatics (Oxford, England)|September 9, 2017
Multiple network-constrained regressions expand insights into influenza vaccination responsesStefan Avey, Subhasis Mohanty, Jean Wilson, et al.Antimicrobial Agents and Chemotherapy|March 23, 2021
A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy ParticipantsTeodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, et al.Eclinicalmedicine|December 8, 2025
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus dolutegravir as a two-drug regimen in adults naive to antiretroviral therapy (DYNAMIC): 24-week results from a randomised phase 2b studySamit R Joshi, Mar Masiá, Essack Mitha, et al.Journal of the International AIDS Society|November 14, 2014
Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysisJacob Lalezari, Gulam H Latiff, Cynthia Brinson, et al.British Journal of Clinical Pharmacology|February 3, 2021
Phase I evaluation of pharmacokinetics and tolerability of the HIV-1 maturation inhibitor GSK3640254 and dolutegravir in healthy adultsTeodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, et al.Pageof 3